Literature DB >> 7845888

The value of sonographic diagnosis of fetal malformations: different results between indication-based and screening-based investigations.

G Bernaschek1, I Stuempflen, J Deutinger.   

Abstract

The advantages of a routine screening or indication-based ultrasound investigation during pregnancy are still under debate. This is the first study where both methods are compared in two different time periods. More malformations were diagnosed before the 24th week of gestation by means of screening-based than indication-based investigation (18 per cent vs. 5 per cent, P < 0.005), and before 28 weeks in 26 per cent compared with 15 per cent respectively (P < 0.01). Twenty-six per cent of all malformations were detected by means of screening-based investigations as opposed to 15 per cent by means of indication-based scans. Primary fetal malformations were also diagnosed much earlier (25 weeks vs. 30 weeks). Except for the fetal head, the detection rate of malformations was higher in nearly all other body regions of the fetus in the screening-based investigation. The most important advantage of a screening-based ultrasound investigation during pregnancy is to detect the malformations early enough in pregnancy for possible intrauterine treatment or to offer safe termination of pregnancy for the woman, at least for those anomalies that are lethal or significantly handicapping.

Entities:  

Mesh:

Year:  1994        PMID: 7845888     DOI: 10.1002/pd.1970140908

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  Assessment of fetus during second trimester ultrasonography using HDlive software: What is its real application in the obstetrics clinical practice?

Authors:  Gabriele Tonni; Gianpaolo Grisolia; Eduardo Félix Santana; Edward Araujo Júnior
Journal:  World J Radiol       Date:  2016-12-28

2.  Another Case of De Novo 3q26.33q27.3 Microdeletion and Its Medicolegal Sequel.

Authors:  Ugo Indraccolo; Salvatore Renato Indraccolo; Piergiorgio Fedeli
Journal:  Case Rep Obstet Gynecol       Date:  2018-02-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.